Maria Fernanda Garcia-Rueda

Maria Fernanda Garcia-Rueda


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Injury
Verified
Journal Article
Closed access
KEKristian A. Espinosa
Kristian A. Espinosa
AGAmparo Gómez Gélvez
Amparo Gómez Gélvez
LTLiliana P. Torres
Liliana P. Torres
MGMaria Fernanda Garcia-Rueda
Maria Fernanda Garcia-Rueda
OPOmar R. Peña
Omar R. Peña

1 July 2005 in Journal of Applied Social Psychology
Verified
Journal Article
Closed access
PDF file
MGMaria Fernanda Garcia-Rueda
Maria Fernanda Garcia-Rueda
RPRamona L. Paetzoldd
Ramona L. Paetzoldd
ACAdrienne Colella
Adrienne Colella

12 December 2024 in Endocrine
Verified
Journal Article
Open access
PDF file
JCJuan Guillermo Cárdenas-Aguilera
Juan Guillermo Cárdenas-Aguilera
VGVladimir González-López
Vladimir González-López
AZAna María Zarante-Bahamón
Ana María Zarante-Bahamón
JPJuan Carlos Prieto-Rivera
Juan Carlos Prieto-Rivera
RBRichard Baquero-Rodríguez
Richard Baquero-Rodríguez
OBOscar Héctor Brunetto
Oscar Héctor Brunetto
Introduction: Hypophosphatasia is a rare inherited systemic metabolic disorder, with an estimated prevalence in the severe forms of the disease of 1/100.000–1/300.000, that affects the typical architecture of bone, leading to defective mineralization during growth and remodeling. It is characterized by loss-of-function variants in the ALPL gene, resulting in low activity of tissue-nonspecific alkaline phosphatase. In severe cases, it can be fatal. Objective: To generate recommendations on the diagnosis, treatment, and follow-up of patients with hypophosphatasia based on available evidence. Materials and methods: A search for evidence published between 2012 and 2024 was carried out in Medline and Embase. The search was expanded with information from various sources, including official sites of development groups, consensuses, technology evaluations, Google Scholar, clinical experts, and reference lists. The quality of the evidence was evaluated according to the type of document type. A modified Delphi consensus process was carried out with external experts, apart from the development group, it was established an 80% agreement threshold to define the final recommendations. Results: Sixty-one papers were found in the evidence search. The global quality of the evidence was low. In addition, a consensus was reached on 94 recommendations regarding diagnosis, treatment, and follow-up. Those recommendations were approved by external clinical experts from Colombia, Argentina, Spain, and Mexico. Conclusions: The recommendations proposed in this document are based on the evidence available to the date the search was carried out, and the judgment of clinical experts. The recommendations on diagnosis, treatment, and follow-up are expected to guide the daily clinical practice for patients with HPP.

24 January 2024 in Revista Colombiana de Nefrología
Verified
Journal Article
Open access
PDF file
JAJuan Guillermo Cárdenas Aguilera
Juan Guillermo Cárdenas Aguilera
AMAdriana Medina-Orjuela
Adriana Medina-Orjuela
AMAdriana Isabel Meza-Martínez
Adriana Isabel Meza-Martínez
JPJuan Carlos Prieto
Juan Carlos Prieto
AZAna María Zarante-Bahamón
Ana María Zarante-Bahamón
OBOscar Brunetto
Oscar Brunetto
Introduction: X-linked hypophosphatemic rickets is a hereditary condition causing disruptions in bone mineral homeostasis. The morbidity associated with this condition has exhibited variability in previous decades, possibly stemming from variations in case definitions and diagnostic confirmation procedures. Objective: Our aim was to generate evidence-informed recommendations for the diagnosis, treatment, and follow-up of patients with suspected or diagnosed XLH. Methodology: Integration of a literature review with a modified Delphi method, guided by expert consensus. Results: Following the screening and selection of 1041 documents, 41 were chosen to address the queries posed by the developer group. Experts, consulted through a modified Delphi consensus, endorsed 97 recommendations on the diagnosis, treatment, and follow-up of patients with suspected or diagnosed XLH. Notably, the quality of the evidence was deemed to be low. Conclusions: The recommendations proposed here will allow early and timely diagnosis of X-linked hypophosphatemic rickets, while optimizing resources for its treatment and follow-up. In addition, it will help clarify the burden of the disease and improve health outcomes for this population. Introducción: el raquitismo hipofosfatémico ligado al cromosoma X es una enfermedad hereditaria que provoca alteraciones en la homeostasis mineral ósea. La morbilidad de este cuadro ha mostrado variabilidad en décadas anteriores e incluso contradicciones, posiblemente debido a la definición del caso y la confirmación diagnóstica. Objetivo: elaborar recomendaciones fundamentadas en evidencia para el diagnóstico, tratamiento y seguimiento de pacientes con sospecha o diagnóstico de XLH. Metodología: revisión de la literatura y consenso de expertos mediante el método Delphi modificado. Resultados: después de llevar a cabo el proceso de tamización y selección de 1,041 documentos, se incorporaron 41 para abordar las preguntas planteadas por el grupo desarrollador. Se obtuvieron 97 recomendaciones sobre el diagnóstico, tratamiento y seguimiento de pacientes con sospecha o diagnóstico de XLH, las cuales fueron aprobadas por expertos consultados mediante un consenso Delphi modificado. Cabe destacar que la calidad de la evidencia fue baja. Conclusiones: las recomendaciones propuestas aquí posibilitarán el diagnóstico temprano y oportuno del raquitismo hipofosfatémico ligado al cromosoma X. Al mismo tiempo, optimizarán la asignación de recursos destinados a su tratamiento y seguimiento, contribuyendo así a dilucidar la carga de enfermedad y a mejorar los resultados de salud en esta población.

14 April 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
MGMaria Fernanda Garcia-Rueda
Maria Fernanda Garcia-Rueda
ABAdriana Patricia Bohorquez-Penaranda
Adriana Patricia Bohorquez-Penaranda
JGJacky Fabian Armando Gil-Laverde
Jacky Fabian Armando Gil-Laverde
FAFrancisco Javier Aguilar-Sierra
Francisco Javier Aguilar-Sierra
CMCamilo Mendoza-Pulido
Camilo Mendoza-Pulido
Background: Acute treatment for distal radius fractures, the most frequent fractures in the pediatric population, represents a challenge to the orthopedic surgeon. Deciding on surgical restoration of the alignment or cast immobilization without reducing the fracture is a complex concern given the remodeling potential of bones in children. In addition, the lack of evidence-based safe boundaries of shortening and angulation, that will not jeopardize upper-extremity functionality in the future, further complicates this decision. Objective: The authors aim to measure functional outcomes, assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Physical Function v2.0 instrument. The authors hypothesize that outcomes will not be worse in children treated with cast immobilization in situ compared with those treated with closed reduction with or without percutaneous fixation. The authors also aim to compare the following as secondary outcomes: ulnar variance and fracture alignment in the sagittal and coronal planes, range of motion, pressure ulcers, pain control, radius osteotomy due to deformity, pseudoarthrosis cure, and remanipulation. Methods: This is the protocol of a randomized noninferiority trial comparing upper-extremity functionality in children aged 5 to 10 years, after sustaining a distal radius fracture, treated with either cast immobilization in situ or closed reduction with or without fixation in a single orthopedic hospital. Functional follow-up is projected at 6 months, while clinical and radiographic follow-up will occur at 2 weeks, 3 months, and 9 months. Results: Recruitment commenced in July 2021. As of January 2022, 23 children have been randomized. Authors expect an average of 5 patients to be recruited monthly; therefore, recruitment and analysis should be complete by October 2024. Conclusions: This experimental design that addresses upper-extremity functionality after cast immobilization in situ in children who have sustained a distal fracture of the radius may yield compelling information that could aid the clinician in deciding on the most suitable orthopedic treatment. Trial Registration: ClinicalTrials.gov NCT05008029; https://clinicaltrials.gov/ct2/show/NCT05008029

16 December 2022 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
MGMaria Fernanda Garcia-Rueda
Maria Fernanda Garcia-Rueda
SNSergio Alejandro Nossa-Almanza
Sergio Alejandro Nossa-Almanza
JJJose Dario Jimenez-Ramirez
Jose Dario Jimenez-Ramirez
CRCamilo Romero-Barreto
Camilo Romero-Barreto
CMCamilo Mendoza-Pulido
Camilo Mendoza-Pulido